Janus Henderson Group PLC
- SEC CIK
- 0001274173
- Latest filing
- May 18, 2026
KROS holding history
Keros Therapeutics, Inc. in every 13F filed by Janus Henderson Group PLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KROS overviewAll 13F holders of KROSFull Q1 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −472,392−100.0% | Sold out | Holders |
| Q2 2025 | 472,392 | $6.31M | <0.1% | +472,392 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −14,307−100.0% | Sold out | Holders |
| Q4 2024 | 14,307 | $226.3K | <0.1% | −77,803−84.5% | Reduced | Holders |
| Q3 2024 | 92,110 | $5.35M | <0.1% | +77,803+543.8% | Added | Holders |
| Q2 2024 | 14,307 | $653.8K | <0.1% | +4,475+45.5% | Added | Holders |
| Q1 2024 | 9,832 | $649.0K | <0.1% | +15+0.2% | Added | Holders |
| Q4 2023 | 9,817 | $390.5K | <0.1% | −15−0.2% | Reduced | Holders |
| Q3 2023 | 9,832 | $313.1K | <0.1% | +30.0% | Added | Holders |
| Q2 2023 | 9,829 | $395.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 9,829 | $419.8K | <0.1% | +9,829 | New | Holders |